SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biohaven’s BHV-1420 Cuts Anti-PLA2R Antibodies by More Than 90% in Mice

Biohaven said BHV-1420 reduced anti-PLA2R antibodies by more than 90% in a mouse study.

BHVN

Related stories